Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Lynch syndrome patients rarely use aspirin for cancer prevention (opens in a new tab)

news-medical.net · 2026-10-09

Short answerEvidenceSource

Short answer

Needs review

Study found.

We found the study, but the claim check did not finish.

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

We found the study behind this story.

We found the study, but couldn't compare the story to it: the study's evidence could not be profiled.

Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

The source study was found, but the study's evidence could not be profiled, so these claims couldn't be checked.

Claim 1 of 6Not checkedInternational studies suggest that taking acetylsalicylic acid daily can protect people with Lynch syndrome from developing colorectal cancer, even at low doses.View evidenceHide evidence

As statedprotect people with Lynch syndrome from developing colorectal cancer; even at low doses

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 2 of 6Not checkedThe CAPP2 study previously showed that a 600 mg daily dose of acetylsalicylic acid could significantly reduce the long-term risk of colorectal cancer in this high-risk group.View evidenceHide evidence

As stated600 milligrams daily

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 3 of 6Not checkedThe CaPP3 study suggests that 100 mg daily could have a similar cancer-preventive profile, with fewer side effects and fewer bleeding complications, although formal equivalence criteria were not met in all analyses and the results should be interpreted with caution.View evidenceHide evidence

As stated100 milligrams daily

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 4 of 6Not checkedIn a survey of 539 people with Lynch syndrome in Germany, 97% knew the screening recommendations and nearly all underwent regular colonoscopies, but only 10.4% reported currently taking acetylsalicylic acid and only 6.9% said they used it specifically for cancer prevention.View evidenceHide evidence

As stated539 people; 97%; 10.4%; 6.9%

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 5 of 6Not checkedThe main reasons for not using aspirin were lack of prior discussion, concerns about side effects, and uncertainty about the scientific evidence.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 6 of 6Not checkedThe survey also found high openness to preventive mRNA cancer vaccines, with about three-quarters willing to consider a study, rising to about 80% after more information, and more than 92% saying they would want such a vaccine if approved.View evidenceHide evidence

As statedthree-quarters; about 80%; more than 92%

Not checked

The source study was found, but this claim couldn't be checked against it.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref, Europe PMC · 39 candidate papers

And 33 more candidates considered.